Key Heterocycle Cores for Designing Multitargeting Molecules provides a helpful overview of current developments in the field. Following a detailed introduction to the manipulation of heterocycle cores for the development of dual or multitargeting molecules, the book goes on to describe specific examples of such developments, focusing on compounds such as Benzimidazole, Acridine, Flavones, Thiazolidinedione and Oxazoline. Drawing on the latest developments in the field, this volume provides a valuable guide to current approaches in the design and development of molecules capable of acting on multiple targets.
Adapting the heterocyclic core of a single-target molecule can facilitate its development into an agent capable of acting on multiple targets. Such multi-targeting drugs have the potential to become essential components in the design of novel, holistic treatment plans for complex diseases, making the design of such active agents an increasingly important area of research.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
1. Multitargeting heterocycles
An improved and rational chemical probes for multifactorial diseases 2. Benzimidazole: Journey from a single targeting to a multitargeting nucleus 3. Acridines: A relatively lesser explored heterocycle for multifactorial diseases 4. Flavone: An important scaffold for medicinal chemistry 5. Thiazolidine-2,4-dione: a potential weapon for targeting multiple pathological conditions 6. Oxindole: A nucleus enriched with multi-targeting potential against complex disorders 7. Thiazine: A Versatile Heterocyclic Scaffold for Multifactorial Diseases 8. Indole: As multi-target directed ligands in medicinal chemistry 9. Triazoles: Multidimensional 5-membered nucleus for designing multitargeting agents 10. Benzoxazolinone: A scaffold with diverse pharmacological significance
Dr. Om Silakari is an assistant professor in the Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, India. He received his Ph.D. degree from Dr. Hari Singh Gour University, India and has been teaching and researching in this area for over 10 years. His research areas include computer-assisted drug designing (CADD) of new anti-inflammatory, antidiabetic and anticancer targets, and the synthesis of new lead molecules. In addition to supervising multiple M. Pharm. and PhD students, he has authored two books and published over 60 papers in international journals. Dr Silakari is an active reviewer for many international journals, has been awarded funding for several research projects, and regularly delivers talks at both national and international conferences.